Asahi Oshima

Asahi Oshima

Auto-generated profile, based on publicly available information

Asahi Oshima

Division of Cardiology Mitsui Memorial Hospital Tokyo Japan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2025 in European Heart Journal
Verified
Journal Article
Open access
PSPatrick Serruys
Patrick Serruys
AOAsahi Oshima
Asahi Oshima
GFGonçalo Ferraz-Costa
Gonçalo Ferraz-Costa
Scot GargScot Garg
Scot Garg
TTTsung‐Ying Tsai
Tsung‐Ying Tsai
YOYoshinobu Onuma
Yoshinobu Onuma
This paper will forecast advancements in coronary revascularization by 2040, drawing on historical trends and recent breakthroughs. Having forecasted in 2000 the impact of innovations like drug-eluting stents, coronary computed tomography angiography, and bioresorbable scaffolds, the authors examine the evolving landscape of coronary artery disease treatment emphasizing artificial intelligence and omics sciences. Imagenomics—the integration of imaging and omics—will be a transformative tool with artificial intelligence enabling more personalized decisions between pharmacological and mechanical revascularization. The shift towards minimally invasive, image-guided procedures is discussed along with the potential obsolescence of current antiplatelet and anticoagulant therapies with novel biomimetic peptides like CD31-covalently bound to metallic or polymeric devices. Advances in photon-counting computed tomography and Fibre Optic Real Shape promise high-resolution imaging with lower radiation, enhancing procedural safety and diagnostic accuracy. It is anticipated that robotics and 3D holograms in percutaneous and surgical revascularization will improve precision and the resulting outcomes. Additionally, the need for mechanical revascularization for younger patients may decline due to effective plaque regression therapies and novel potent anti-atherogenic biologics. However, the aging population will drive demand for mechanical interventions, with advancements in atherectomy and lithotripsy techniques improving outcomes in complex, calcified lesions. This comprehensive analysis outlines a future where myocardial revascularization becomes increasingly personalized, with technology-driven interventions redefining cardiovascular medicine.

9 October 2025 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
PRPruthvi C. Revaiah
Pruthvi C. Revaiah
TTTsung‐Ying Tsai
Tsung‐Ying Tsai
JFJacopo Farina
Jacopo Farina
GFGonçalo Ferraz-Costa
Gonçalo Ferraz-Costa
JJJochem Jongenotter
Jochem Jongenotter
PSPatrick Serruys
Patrick Serruys

14 April 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
AOAsahi Oshima
Asahi Oshima
KNKai Ninomiya
Kai Ninomiya
MSMasahiro Sekiguchi
Masahiro Sekiguchi
DYDaiki Yoshiura
Daiki Yoshiura
YGYuki Gonda
Yuki Gonda
MAMasahiko Asami
Masahiko Asami

28 July 2026 in European Heart Journal - Quality of Care and Clinical Outcomes
Verified
Journal Article
Open access
AOAsahi Oshima
Asahi Oshima
NKNozomu Kanehama
Nozomu Kanehama
DKDavid van Klaveren
David van Klaveren
JSJudith Schlueter
Judith Schlueter
NLNeil O’ Leary
Neil O’ Leary
PSPatrick Serruys
Patrick Serruys
Aims: Accurate risk stratification for patients with three-vessel coronary artery disease (3VD) undergoing percutaneous coronary intervention (PCI) remains important in contemporary practice. Synergy between PCI with Taxus and cardiac surgery (SYNTAX)-based mortality prediction models require reassessment in modern PCI populations. Methods and results: This post hoc analysis of the Multivessel TALENT trial evaluated the core and extended logistic clinical SYNTAX Score (LCSS) for predicting 1-year all-cause mortality. Discrimination was assessed using the area under the receiver-operating characteristic curve (AUC), and calibration using calibration intercept, calibration slope, graphical calibration, and the E-statistic. Prediction scores were calculated within each of 20 imputed datasets, with model performance evaluated within each imputation and summarized across imputations. Intercept-and-slope recalibration and decision curve analysis were also performed. At 1 year, 46 (3.0%) of 1548 enrolled patients had died. The pooled AUCs were 0.716 for the LCSS core model and 0.744 for the extended model, compared with 0.629 for the anatomical SYNTAX Score and 0.632 for the functional SYNTAX Score. LCSS models systematically overestimated absolute risk, although observed mortality increased across predicted-risk quintiles. Decision curve analysis showed a positive net benefit for the original and recalibrated LCSS models across threshold probabilities of 1–10%, with numerically higher net benefit for the recalibrated extended model across much of the evaluated threshold range. Conclusion: In contemporary PCI for 3VD, the LCSS showed moderate discrimination for 1-year all-cause mortality while overestimating its absolute risk. Recalibration improved agreement with observed risk in this cohort and may inform future validation and model refinement.

28 October 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
AOAsahi Oshima
Asahi Oshima
TTTsung-Ying Tsai
Tsung-Ying Tsai
CCChun-Chin Chang
Chun-Chin Chang
KNKai Ninomiya
Kai Ninomiya
KMKotaro Miyashita
Kotaro Miyashita
PSPatrick Serruys
Patrick Serruys

13 September 2026 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
AOAsahi Oshima
Asahi Oshima
YHYu Horiuchi
Yu Horiuchi
TMTakuya Matsumoto
Takuya Matsumoto
KIKazushige Ito
Kazushige Ito
Scot GargScot Garg
Scot Garg
NMNaobumi Mise
Naobumi Mise